Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sonia Kosow Guterman is active.

Publication


Featured researches published by Sonia Kosow Guterman.


Expert Opinion on Therapeutic Patents | 1997

Inhibitors of human neutrophil elastase

Sonia Kosow Guterman; Rachel Baribault Kent; Robert Charles Ladner; Arthur Charles Ley; William Markland; Bruce L. Roberts

Human neutrophil elastase (HNE) is a serine protease that is responsible for a number of diverse pathological conditions. Synthetic inhibitors which can regulate the in vivo activity of HNE will therefore have broad therapeutic applications. Over the past 15 years a diverse set of strategies have been pursued for the development of HNE inhibitors, the most successful of which have been electrophilic ketones and acylating agents. Many of these inhibitors have been demonstrated to prevent the deleterious effects of elastase-mediated proteolysis in a number of in vivo models. This report reviews electrophilic ketones and acylating agents that have appeared in the patent literature since 1993. Supporting primary literature which highlights the therapeutic potential of these inhibitors is also included.


Molecular Genetics and Genomics | 1979

Rifampicin supersensitivity of rho strains of E. coli, and suppression by sur mutation.

Sonia Kosow Guterman; C. Linda Howitt

SummaryEscherichia coli strains with mutations rho-115, rho-ts15, rho-101 (psu-1) or rho-102 (psu-2) are more sensitive (“supersensitive”) to rifampicin than isogenic parent strains, as measured by growth rate in broth and colony forming efficiency on solid media with 5, 10, or 20 μg of rifampicin per ml. There is no change in sensitivity of rho mutants to the antibiotics penicillin, erythromycin, chloramphenicol, or the detergent desoxycholate. The rho-101 or rho-102 mutations confer rifampicin supersensitivity at 32°C but not 42°C. Mutants of a rho-115 strain that have lost polarity suppression can be isolated by selection for rifampicin resistance. This phenotype, Sur, is not due to reversion of the original rho gene mutation but to a second mutation perhaps in the gene for rho protein or the gene for the β subunit of RNA polymerase. One class of Sur mutation, occurring in rho-115 cells isolated as resistant to 20 μg of rifampicin per ml, is co-transducible with the marker ilv, and the gene order is rbs-ilv-sur-38. A model suggested by this map position is that the mutations rho-115 and sur-38 define the domain of rho protein which interacts with the β subunit of RNA polymerase.


Molecular Genetics and Genomics | 1984

Autoregulation of the rho gene of Escherichia coli K-12

Hsiang-Fu Kung; Eva Bekesi; Sonia Kosow Guterman; John E. Gray; Lisa Traub; David H. Calhoun

SummaryIt has previously been proposed, based on indirect evidence, that the Rho protein may control the expression of the rho gene. Using an in vitro system for the transcription and translation of the rho gene cloned into plasmid pBR322, we tested this hypothesis directly by monitoring the effect in vitro of excess or limiting Rho protein. The addition of purified Rho protein suppresses Rho synthesis in vitro. The addition of antibody to Rho specifically stimulates Rho synthesis in vitro. The stimulation of Rho factor synthesis by antibody to Rho is reversed by Rho protein. Rho factor purified from a strain with a mutationally altered rho gene (rho-115) does not suppress Rho synthesis in vitro. These results provide convincing evidence that the rho gene is subject to autoregulation.


Molecular Genetics and Genomics | 1981

A mutant rho ATPase from Escherichia coli that is temperature-sensitive in the presence of RNA

Rachel Baribault Kent; Sonia Kosow Guterman

SummaryThe Escherichia coli mutant rho-115 suppresses lac operon polarity conferred by the lacZ::IS1 insertion MS319. The ATPase activity of purified rho-115 protein was maximal at 40°C, in contrast to 45°C for rho+. At higher temperatures (50°C, 55°C), the fractions of activities at maximal temperature were consistently lower for rho-115 compared to rho+. The 30-minute time course of rho-115 ATP hydrolysis was linear at 37°C but at 45°C the linear kinetics of hydrolysis reached a plateau between 10 and 15 minutes. The 30-minute time courses for rho+ were linear at both 37°C and 45°C. The rho-115 and rho+ ATPase activities were equally heat-stable during preincubation at 45°C in buffer. Inclusion of ATP during preincubation protected these rho proteins from inactivation to the same extent. The presence of polyC during preincubation protected rho- activity but produced substantial inactivation of rho-115 ATPase. The presence of polyU during preincubation gave similar results. Concentrations of polyC between 625 ng/ml and 100 μg/ml yielded the same extent of rho-115 ATPase inactivation during preincubation at 45°C. Thermal inactivation of rho-115 ATPase by polyC was halted by shifting preincubation temperature from 45°C to 35°C, indicating that polyC-induced destabilization of rho-115 was irreversible.


Molecular Genetics and Genomics | 1984

Location of the rho gene and characterization of λ ilv-gal derivatives of λ ilv-rho bacteriophage

David H. Calhoun; Lisa Traub; John W. Wallen; John E. Gray; Sonia Kosow Guterman

SummaryThe location of the rho gene and its position relative to the ilv genes of Escherichia coli K-12 was analyzed using genetic criteria, restriction enzyme cleavage, and maxicell analysis. Plasmids were constructed with deletions of the rho gene introduced in vitro, and λ ilv-gal derivatives of λ ilv-rho bacteriophage were isolated by recombination in vivo. A HindIII restriction fragment of 8 kilobases (kb) previously shown to contain at least part of the rho gene (Gray et al. 1981) was cloned into plasmid pMC81. This vector has transcription stop sites that present read-through expression of cloned genes from either direction, and cloning sites upstream of the lacZ gene coding for β-galactosidase. The position of the rho gene and flanking sequences required for its expression were further localized to a region of approximately 2 kb by introducing deletions using restriction enzyme treatment of these plasmids. A promoter in the rho region was found to direct β-galactosidase synthesis in these plasmid derivatives. Derivatives of λ ilv-rho phage were isolated in vivo by pyrophosphate chelation selection for phage with reduced genome size. Restriction enzyme analysis of twelve of these derivatives revealed an unexpected bias towards phage recombinants as opposed to simple internal deletions.


Molecular Genetics and Genomics | 1982

Temperature-sensitive mutant rho-115 rho-RNA binary complexes, and stabilization by substrates and analogues

Rachel Baribault Kent; Sonia Kosow Guterman

SummaryTo determine the molecular basis for the temperature-sensitivity of pure rho RNA-dependent ATPase from Escherichia coli mutant rho-115 cells, we investigated mutant rho binding to [3H] polyC as measured by retention on nitrocellulose filters. Complexes of wild-type rho and polyC incubated at 37°C and 45°C were similarly stable. At 37°C mutant rho-polyC binary complexes were inactivated at a slightly faster rate than complexes with wild-type rho. Upon shift to 45°C the quantity of rho-115 bound to polyC declined immediately, resulting in one-fifth of the quantity of complexes observed at 37°C. Shift back to 37°C restored the level of observed complexes by two-fold. The inclusion of ATP or the analogue β-γ methylene ATP during 45°C incubation resulted in stable mutant rho-polyC complexes. The hydrolysis product ADP was also effective in stabilizing binary complexes at 45°C but this effect was observed with an order of magnitude more ADP than ATP. Adenine, adenosine, AMP or Pi had no stabilizing effect. We conclude that the mutant rho-115 protein exhibits a structural instability as a result of binding RNA. Furthermore ATP confers a wild-type phenotype upon rho-115 protein, probably as a result of conformational change due to binding of this compound. The effect of ATP on the stability of mutant rho-polyC binary complexes supports the model of ATP modulation of rho-RNA interaction proposed by Galluppi and Richardson (1980).


Molecular Genetics and Genomics | 1980

Second-site rho mutation: Genetic linkage and polyC-dependent ATPase

Sonia Kosow Guterman; C. Linda Howitt; Gail Singer

SummaryRho has been purified to homogeneity from Escherichia coli double mutant rho-115 sur-38 cells, and from rho++ and rho-115 cells. The sur-38 mutation suppresses the original rho-115 phenotype. We observe that the polyC-dependent ATPases of these three rho preparations have the same specific activities. However, the ATPase of rho from the double rho-115 sur-38 mutant is extremely heat labile, while that from rho-115 shows a heat lability intermediate between the wild type and the double mutant.Transduction analysis suggests that sur-38 is closely linked to rho-115 in the order ilv-sur-38-rho-115-metE. These data are consistent with the model that the sur-38 mutation affects the structural gene for rho.


Archive | 2001

Directed evolution of novel binding proteins

Robert Charles Ladner; Sonia Kosow Guterman; Bruce L. Roberts; William Markland; Arthur Charles Ley; Rachel Baribault Kent


Archive | 1993

Viruses expressing chimeric binding proteins

Robert Charles Ladner; Sonia Kosow Guterman; Bruce L. Roberts; William Markland; Arthur Charles Ley; Rachel Baribault Kent


Archive | 1989

Generation and selection of recombinant varied binding proteins

Robert Charles Ladner; Sonia Kosow Guterman

Collaboration


Dive into the Sonia Kosow Guterman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David H. Calhoun

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

John E. Gray

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Lisa Traub

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

David White

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge